Prices are updated after-hours

Manufacturing 4

Algoma Steel Group Inc.

ASTL | $7.74 -4.21% -4.39% 750K

|

(0.0% 1d) (3.9% 1m) (8.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (134.78% volume)
Earnings Calendar:
Market Cap: $ 805,757,777
https://www.algoma.com
Sec Filling | Patents | n/a employees

(CA) Based in Sault Ste. Marie, Ontario, Canada, Algoma is a fully integrated producer of hot and cold rolled steel products including sheet and plate. With a current raw steel production capacity of an estimated 2.8 million tons per year, Algoma’s size and diverse capabilities enable it to deliver responsive, customer-driven product solutions straight from the ladle to direct applications in the automotive, construction, energy, defense, and manufacturing sectors. Algoma is a key supplier of steel products to customers in Canada and Midwest USA and is the only producer of plate steel products in Canada. Algoma’s mill is one of the lowest cost producers of hot rolled sheet steel (HRC) in North America owing in part to its state-of-the-art Direct Strip Production Complex ("DSPC"), which is the newest thin slab caster in North America with direct coupling to a basic oxygen furnace (BOF) melt shop. Algoma has achieved several meaningful improvements over the last several years that are expected to result in enhanced long-term profitability for the business. Algoma has upgraded its DSPC facility and recently installed its No. 2 Ladle Metallurgy Furnace. Additionally, Algoma has cost cutting initiatives underway and is in the process of modernizing its plate mill facilities. Today Algoma is returning to its roots as a customer-focused, entrepreneurial company with the courage and growing capability to meet the industry’s challenges head-on. It is investing in its people and processes, optimizing and modernizing so that it will continue to be your partner in steel.

profitable msa energy optical automotive defense

add to watch list Paper trade email alert is off

FUEL DOCTOR HOLDINGS, INC.

FDOC | $0.286 -23.08% 150

|

(0.0% 1d) (0.0% 1m) (219.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-99.5% volume)
Earnings Calendar:
Market Cap: $ 392,579,624

Sec Filling | Patents | n/a employees

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNKKQ | $0.02

|

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (10.5% 3d) (0.0% 7d) (-51.93% volume)
Earnings Calendar:
Market Cap:
http://www.mallinckrodt.com/
Sec Filling | Patents | 3085 employees

(IE) Mallinckrodt Pharmaceuticals is an Irish–tax registered manufacturer of specialty pharmaceuticals , generic drugs and imaging agents. In 2017 it generated 90% of sales from the U.S. healthcare system. While Mallinckrodt is headquartered in Ireland for tax purposes, its operational headquarters are in the U.S. Mallinckrodt's 2013 tax inversion to Ireland drew controversy when it was shown Acthar, was Medicaid's most expensive drug. Mallinckrodt acquires , manufactures, and distributes products used in diagnostic procedures and in the treatment of pain and related conditions. This includes the acquisition, manufacture, and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, contrast products, and radiopharmaceuticals. The company employed 5,500 and had net sales of $3.2 billion in 2017; of which $2.9 billion was from the U.S. healthcare system.

diagnostics acquisitions treatment

add to watch list Paper trade email alert is off

Mallinckrodt plc

MNKTQ | $0.12 -66.67% 39K

|

(0.0% 1d) (0.0% 1m) (-36.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-97.94% volume)
Earnings Calendar:
Market Cap: $ 1,594,702
http://www.mallinckrodt.com/
Sec Filling | Patents | 3046 employees

(IE) mallinckrodt is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal respiratory critical care therapies; and analgesics and central nervous system drugs. the company's core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. the company's specialty brands segment includes branded medicines; its specialty generics segment includes specialty generic drugs, active pharmaceutical ingredients and external manufacturing; and the global medical imaging segment includes contrast media and nuclear imaging agents. to learn more about mallinckrodt, visit

add to watch list Paper trade email alert is off

Femasys Inc

FEMY | News | $1.33 1.53% 1.5% 160K

|

(0.0% 1d) (-28.9% 1m) (48.8% 1y) (0.0% 2d) (-1.5% 3d) (-4.5% 7d) (-100.0% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 29,392,132

Sec Filling | Patents | 35 employees

our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. the team is complemented by world-class medical advisors. our products have been organically conceived, researched and developed by the company and all manufacturing activities are conducted to ensure compliance with the u.s. food and drug administration (fda) per the requirements of 21 cfr 820, as well as iso 13485. femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the u.s. food and drug administration (fda), european union, canada, and japan with other select countries in process. making a difference in t

contraception

add to watch list Paper trade email alert is off

Pineapple Holdings, Inc.

PEGY | $0.0501 4.38% 4.19% 9.2M

|

(0.0% 1d) (-23.1% 1m) (-96.4% 1y) (0.0% 2d) (0.0% 3d) (2.0% 7d) (52.65% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 3,210,264

Sec Filling | Patents | 150 employees

Communications Systems, Inc., an IoT intelligent edge products and services company, provides network infrastructure and services for global deployments of enterprise and industrial networks. CSI operates under its Electronics & Software and Services & Support operating segments. Electronics & Software segment provides smart, flexible solutions at network edge, by giving customers the ability to easily provision and proactively manage their networks with actionable insights about their edge devices and connected end points, thereby minimizing the administrative burden of the operator. Services & Support segment provides fully managed services for all aspects of design, deployment, support and maintenance of customer networks. With partners and customers in over 50 countries, CSI has built a reputation as a reliable global innovator focusing on quality and customer service.

electronics device trial system solutions software intel active services works work communication smart service communications iot tiona msa

add to watch list Paper trade email alert is off

SciSparc Ltd

SPRC | $1.235 -4.26% -4.45% 150K

|

(0.0% 1d) (-39.4% 1m) (131.6% 1y) (0.0% 2d) (0.0% 3d) (-11.4% 7d) (-65.29% volume)
Earnings Calendar:
Market Cap: $ 872,754

Sec Filling | Patents | 2020 employees

add to watch list Paper trade email alert is off

enVVeno Medical Corporation

NVNO | $4.65 -2.72% -2.8% 71K

|

(0.0% 1d) (-16.4% 1m) (8.8% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (10.86% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 61,924,050
https://www.hancockjaffe.com
Sec Filling | Patents | 19 employees

(US) Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.

add to watch list Paper trade email alert is off

Ipsidy Inc

AUID | News | $7.59 -5.95% -6.32% 21K

|

(0.0% 1d) (-19.2% 1m) (95.6% 1y) (0.0% 2d) (0.0% 3d) (-3.2% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 71,727,170
https://www.ipsidy.com/
Sec Filling | Patents | 60 employees

(United States) Ipsidy, Inc. rebranded as authID.ai Recognise Your Customer™. Its mission is to eliminate all passwords, and to be the preferred global platform for biometric identity authentication. The authID.ai Identity as a Service (IDaaS) platform delivers a suite of biometric Its proofing and authentication solutions that establish security and trust in today’s digital world. Its vision is to enable every organization to “Recognise Your Customer” instantly, without friction or loss of privacy, powered by the most sophisticated biometric and artificial intelligence technologies.

msa security

add to watch list Paper trade email alert is off

Treace Medical Concepts Inc

TMCI | $10.97 -2.66% -2.73% 380K

|

(0.0% 1d) (-8.8% 1m) (-56.6% 1y) (0.0% 2d) (0.0% 3d) (-4.2% 7d) (Infinity% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 677,453,952
https://www.treace.com
Sec Filling | Patents | 133 employees

(US) Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion Correction™ system is designed to reproducibly correct all three planes of the bunion deformity and address the root cause of the bunion, while allowing patients to get back to their active lives quickly.

3d

add to watch list Paper trade email alert is off

Pluri Inc

PLUR | $5.22 3.37% 3.26% 24K

|

(0.0% 1d) (438.5% 1m) (442.8% 1y) (0.0% 2d) (0.0% 3d) (-8.8% 7d) (946.03% volume)
Earnings Calendar:
Market Cap: $ 216,526,498
https://www.pluristem.com
Sec Filling | Patents | 152 employees

(IL) Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented PLX cell product candidates and is currently conducting late-stage clinical trials in several indications. PLX cell product candidates are believed to release a range of therapeutic proteins in response to inflammation, muscle trauma, hematological disorders and radiation damage. The cells are grown using the Company's proprietary three-dimensional expansion technology and can be administered to patients off- the-shelf, without tissue matching. Pluristem has a strong intellectual property position; a

t-cell

add to watch list Paper trade email alert is off

Applied Blockchain, Inc.

APLD | $2.465 3.14% 3.04% 3.2M

|

(0.0% 1d) (-47.3% 1m) (-24.1% 1y) (0.0% 2d) (0.0% 3d) (-2.6% 7d) (-4.01% volume)
Earnings Calendar: 2024-01-16
Market Cap: $ 302,552,966

Sec Filling | Patents | 5 employees

add to watch list Paper trade email alert is off

Kiora Pharmaceuticals Inc

KPRX | $0.502 -1.57% -1.59% 49K

|

(0.0% 1d) (-15.9% 1m) (-85.5% 1y) (0.0% 2d) (0.0% 3d) (-8.9% 7d) (29.66% volume)
Earnings Calendar: 2024-03-25
Market Cap: $ 13,180,611
https://eyegatepharma.com
Sec Filling | Patents | 14 employees

(United States) EyeGate Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate's lead product, Ocular Bandage Gel ('OBG'), is based on a modified form of the natural polymer hyaluronic acid. The objective of OBG is to protect the ocular surface in order for the body to re-epithelialize the cornea and improve ocular surface integrity. The product is applied as a clear topical gel, to the damaged ocular surface, and possesses unique properties that help hydrate and protect the ocular surface to allow for wound healing. EyeGate is in clinical evaluation for two different patient populations: (1) patients undergoing photorefractive keratectomy ('PRK') surgery to demonstrate corneal wound repair after refractive surgery; and (2) patients with punctate epitheliopathies ('PE') as a result of dry eye to promote reduction of PEs.

msa

add to watch list Paper trade email alert is off

Lightwave Logic Inc

LWLG | $4.02 -1.95% -1.99% 770K

|

(0.0% 1d) (-3.8% 1m) (-8.7% 1y) (0.0% 2d) (0.0% 3d) (3.5% 7d) (44.85% volume)
Earnings Calendar:
Market Cap: $ 480,790,251
https://www.lightwavelogic.com
Sec Filling | Patents | 19 employees

(US) Lightwave Logic, Inc. is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The Company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets.

photo communication optical eletrical

add to watch list Paper trade email alert is off

Nexgel Inc

NXGL | News | $2.21 -1.4% 1.2K

|

(0.0% 1d) (-15.7% 1m) (41.5% 1y) (0.0% 2d) (0.0% 3d) (3.2% 7d) (-95.65% volume)
Earnings Calendar: 2023-03-27
Market Cap: $ 13,763,049
https://nexgel.com
Sec Filling | Patents | 8 employees

NEXGEL advanced hydrogel solutions is your skin friendly patch company! Its ultra-gentle, high-water content hydrogels are an excellent transdermal drug delivery system for a broad range of OTC and Cosmetic ingredients. Its hydrogels are gentler than most because NEXGEL doesn’t use chemical cross-linking agents or chemical adhesives to deliver its ingredients. Instead, NEXGEL uses a unique electron-beam cross linking process to create the bond. By using NEXGEL you can rest assured that you have one of the gentlest transdermal delivery systems on the market.

skin electronics

add to watch list Paper trade email alert is off

ARS Pharmaceuticals Inc

SPRY S | $8.47 0.36% 0.35% 490K

|

(0.0% 1d) (4.1% 1m) (37.3% 1y) (0.0% 2d) (0.0% 3d) (-1.9% 7d) (-4.32% volume)
Earnings Calendar: 2023-11-14
Market Cap: $ 817,368,162
https://silverbacktx.com
Sec Filling | Patents | 54 employees

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

msa

add to watch list Paper trade email alert is off

Lifecore Biomedical Inc

LFCR | $6.69 5.94% 5.61% 170K

|

(0.0% 1d) (30.3% 1m) (66.2% 1y) (0.0% 2d) (0.0% 3d) (4.5% 7d) (-100.0% volume)
Earnings Calendar: 2023-10-05
Market Cap: $ 202,855,311
https://www.landec.com
Sec Filling | Patents | 796 employees

(US) Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.

msa brands injection

add to watch list Paper trade email alert is off

Amplitech Group Inc

AMPG | $2.39 7.66% 7.11% 6.8K

|

(0.0% 1d) (22.6% 1m) (-28.1% 1y) (0.0% 2d) (0.0% 3d) (-3.4% 7d) (-72.53% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 23,223,900
https://www.amplitechinc.com
Sec Filling | Patents | 16 employees

AmpliTech Group, Inc. designs, develops, and manufactures custom and standard state-of-the-art RF components for the Domestic and International, SATCOM, Space, Defense and Military markets. These designs cover the frequency range from 50 kHz to 40 GHz - eventually, offering designs up to 100 GHz. AmpliTech also provides consulting services to help with any microwave components or systems design problems. Its steady growth over the past 13+ years has come about because AmpliTech can provide complex, custom solutions for nearly ANY custom requirements that are presented. In addition, AmpliTech has the best assemblers, wires, and technicians in the industry and can provide contract assembly of customers' own designs.

military defense

add to watch list Paper trade email alert is off

Regal Rexnord Corp

RRX | $159.71 2.41% 0.0% 640K

|

(0.0% 1d) (-10.2% 1m) (23.3% 1y) (0.0% 2d) (0.0% 3d) (-1.8% 7d) (14.11% volume)
Earnings Calendar: 2024-02-07
Market Cap: $ 10,608,675,581
https://www.regalbeloit.com
Sec Filling | Patents | 2021 employees

(US) Regal Beloit Corporation is a global leader in the engineering and manufacturing of electric motors and controls, power generation solutions, and power transmission products serving customers throughout the world. Regal creates a better tomorrow by developing and responsibly producing energy-efficient products and systems. The company is comprised of four operating segments: Commercial Systems, Industrial Systems, Climate Solutions, and Power Transmission Solutions. Regal is headquartered in Beloit, Wisconsin and has manufacturing, sales and service facilities worldwide.

energy eletrical

add to watch list Paper trade email alert is off

Inspira Technologies Oxy B.H.N. Ltd

IINN | $1.83 1.11% 1.1% 91K

|

(0.0% 1d) (0.0% 1m) (53.4% 1y) (0.0% 2d) (-4.7% 3d) (-6.2% 7d) (-43.69% volume)
Earnings Calendar:
Market Cap: $ 28,643,482
https://inspira-technologies.com
Sec Filling | Patents | 2021 employees

Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology, which it believes will elevate and stabilize patient oxygen saturation levels. The Company's ART technology potentially allows patients to remain awake during treatment while minimizing the use of the highly invasive, risky and costly mechanical ventilation systems that require medically induced coma. The Company's products have not yet been tested or used in humans and has not approved by the U.S. Food and Drug Administration (FDA).

treatment blood sensors respiratory

add to watch list Paper trade email alert is off

← Previous
1
2
Next →

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M

|

EGOX | $0.0515 43.06% 30.1% 330M

|

OLB 4 | $0.33 -14.95% 25.53% 840K

|

Technology Services

NVFY | $2.77 31.28% 23.83% 33M

|

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M

|

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M

|

Distribution Services

INSG | $3.03 25.21% 20.13% 330K

|

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K

|

WLGS | News | $0.59 18.0% 17.9% 2.3M

|

ASNS | $0.828 21.75% 17.86% 18K

|

Last 48 Hours Insiders Buying

RKT | News P 380 | $11.68 1.3% 0.17% 1.9M

|

| 22:30
HROW | $10.43 -3.87% -4.03% 680K

|

Health Technology

| 22:30
BCDA | $0.377 -1.4% 97K

|

Health Technology

| 22:00
CLSD | $1.29 -2.27% -2.33% 230K

|

Health Technology

| 14:00
CDZI P 25000 | $2.25 0.0% 260K

|

| 14:00
ETST P 39000 | $0.068 -67.14% 43K

|

| 13:30
FNLC P 1275 | $22.97 3.66% 3.53% 21K

|

| 12:30
ADMQ | $0.0532 -40.18% 480K

|

| 10:30
AXR P 2400 | $21.0 -5.28% 0.0% 13K

|

| 21:00
QCRH P 118 | $57.315 3.44% 3.32% 66K

|

| 18:01
VUZI P 7500 | $1.19 -5.56% -5.88% 550K

|

Electronic Technology

| 18:00
RMCF | $3.67 3.38% 3.27% 11K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar